Phase IIb Clinical Trial for the Efficacy and Safety by CU01-1001 for 24 Weeks in Type 2 DM Patients With Albuminuria

Dose-finding Study of KHK7791 in Hyperphosphatemia Patients

NCT03864458 ·Status: COMPLETED ·Phase: PHASE2

A Study of Patients With Chronic Kidney Disease to Assess the Safety of a Single Dose of COR-001

NCT03126318 ·Status: COMPLETED ·Phase: PHASE1

A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease

NCT06522997 ·Status: COMPLETED ·Phase: PHASE2

Feasibility of Study of Empagliflozin in Patients With Autosomal Dominant Polycystic Kidney Disease

NCT05510115 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy

NCT05707377 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

A Phase 2, Multi-center, Open-label, Dose-finding Trial to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of OPC-41061 in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration

NCT01876381 ·Status: COMPLETED ·Phase: PHASE2

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of HSK21542 Injection in Subjects Undergoing Hemodialysis

NCT04470154 ·Status: COMPLETED ·Phase: PHASE2

CKD-11101 Phase 3 IV Study in Patients Who Had Renal Anemia Receiving Hemodialysis

NCT03428594 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(5) 80/20/10mg

NCT05698043 ·Status: COMPLETED ·Phase: PHASE1

Study to Investigate the Safety of LT5001 Drug Product for Uremic Pruritus in Hemodialysis Patients

NCT04393675 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

PK Study in Subjects With Renal Impairment (Severe and if Required Mild & Moderate) Compared to Subjects With Normal Renal Function

NCT04656795 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Effects of GLPG2737 in Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

NCT04578548 ·Status: TERMINATED ·Phase: PHASE2

Efficacy, Safety and Tolerability of Balcinrenone/Dapagliflozin Compared to Dapagliflozin in Adults With Chronic Kidney Disease

NCT06350123 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess S-217622 in Participants With Renal Impairment and Healthy Participants

NCT05363215 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney Disease

NCT06734234 ·Status: RECRUITING ·Phase: PHASE1

A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Study 156-04-001]

NCT00841568 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB054707 in Participants With Normal and Impaired Renal Function and Participants on Hemodialysis

NCT05624723 ·Status: COMPLETED ·Phase: PHASE1

Everolimus on CKD Progression in ADPKD Patients

NCT01009957 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Dose-Titration Study of Sevelamer Carbonate in Chronic Kidney Disease (CKD) Patients on Hemodialysis

NCT01736150 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney Disease

NCT04492722 ·Status: TERMINATED ·Phase: PHASE2

CR845-CLIN3103: A Global Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus

NCT03636269 ·Status: COMPLETED ·Phase: PHASE3

A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With AION-301 Administered by Intravenous Infusion Compared With Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age With Chronic Kidney Disease (CKD)

NCT06721143 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy

NCT05668403 ·Status: RECRUITING ·Phase: PHASE1

Triptolide-Containing Formulation as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)

NCT02115659 ·Status: UNKNOWN ·Phase: PHASE3

Comparative Evaluation of Pharmacokinetics After CKD-501 Between Renal Impaired and Normal Renal Function Subjects

NCT02007941 ·Status: COMPLETED ·Phase: PHASE1